PAFAH1B3 Polyclonal antibody
PAFAH1B3 Polyclonal Antibody for ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, ELISA
Conjugate
Unconjugated
Cat no : 10634-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| WB | See 1 publications below |
Product Information
10634-1-AP targets PAFAH1B3 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | PAFAH1B3 fusion protein Ag0986 相同性解析による交差性が予測される生物種 |
| Full Name | platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa |
| Calculated molecular weight | 26 kDa |
| GenBank accession number | BC007863 |
| Gene symbol | PAFAH1B3 |
| Gene ID (NCBI) | 5050 |
| RRID | AB_2160048 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
PAFAH1B3(Platelet-activating factor acetylhydrolase IB subunit gamma) is also named as PAF-AH 29 kDa subunit,PAFAHG and belongs to the 'GDSL' lipolytic enzyme family.It catalyzes the removal of the acetyl group at the sn-2 position of the glycerol backbone of platelet-activating factor (PAF), producing biologically inactive lyso-PAF.It is one of the three subunits of cytosolic PAF-AH IB.
Publications
| Species | Application | Title |
|---|---|---|
J Biol Chem Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2). |
